Found: 10
Select item for more details and to access through your institution.
Pharmaceutical Prevention and Management of Cardiotoxicity in Hematological Malignancies.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 8, p. 1007, doi. 10.3390/ph15081007
- By:
- Publication type:
- Article
Flow cytometric predictive scoring systems for common fusions ETV6/RUNX1, BCR/ABL1, TCF3/PBX1 and rearrangements of the KMT2A gene, proposed for the initial cytogenetic approach in cases of B‐acute lymphoblastic leukemia.
- Published in:
- International Journal of Laboratory Hematology, 2019, v. 41, n. 3, p. 364, doi. 10.1111/ijlh.12983
- By:
- Publication type:
- Article
Prenatal Diagnosis of Thalassemia Intermedia: Is It Justified?
- Published in:
- Annals of the New York Academy of Sciences, 1990, v. 612, n. 1, p. 521, doi. 10.1111/j.1749-6632.1990.tb24351.x
- By:
- Publication type:
- Article
Contribution of immunophenotype to the investigation and differential diagnosis of Burkitt lymphoma, double‐hit high‐grade B‐cell lymphoma, and single‐hit MYC‐rearranged diffuse large B‐cell lymphoma.
- Published in:
- Cytometry. Part B, 2020, v. 98, n. 5, p. 412, doi. 10.1002/cyto.b.21887
- By:
- Publication type:
- Article
Evaluation of bone involvement in patients with Gaucher disease: a semi-quantitative magnetic resonance imaging method (using ROI estimation of bone lesion) as an alternative method to semi-quantitative methods used so far.
- Published in:
- European Journal of Haematology, 2015, v. 95, n. 4, p. 342, doi. 10.1111/ejh.12504
- By:
- Publication type:
- Article
Comparison of allogeneic stem cell transplantation, high-dose cytarabine, and autologous peripheral stem cell transplantation as postremission treatment in patients with de novo acute myelogenous leukemia (The following Hospitals and Physicians participated in the study: First Department of Internal Medicine, National University of Athens, Medical School, Laiko General Hospital (D. Loukopoulos, A. M. Tsimberidou, N. Viniou, N. Stavroyianni, J. Meletis, C. Constantopoulos, E. Variami, T. Andreopoulos, Y. Rombos, and X. Yataganas); Department of Clinical Propedeutic National University of Athens Medical School, Laiko General Hospital (P. Panagiotidis); Second Department of Internal Medicine, National University of Athens Medical School, Hippokration General Hospital (Th. Kalmantis and M. Belegrati); Department of Internal Medicine, Division of Hematology,University Hospital of Patras, Rion-Patras (N. Zoumbos, T. Matsouka, M. Tin)
- Published in:
- Cancer (0008543X), 2003, v. 97, n. 7, p. 1721, doi. 10.1002/cncr.11240
- By:
- Publication type:
- Article
Real‐life experience with the combination of polatuzumab vedotin, rituximab, and bendamustine in aggressive B‐cell lymphomas.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 3, p. 336, doi. 10.1002/hon.2842
- By:
- Publication type:
- Article
Cardioprotective effect of metoprolol and enalapril in doxorubicin-treated lymphoma patients: A prospective, parallel-group, randomized, controlled study with 36-month follow-up.
- Published in:
- American Journal of Hematology, 2010, v. 85, n. 11, p. 894, doi. 10.1002/ajh.21840
- By:
- Publication type:
- Article
The Cytogenetic Profile of Primary and Secondary Plasma Cell Leukemia: Etiopathogenetic Perspectives, Prognostic Impact and Clinical Relevance to Newly Diagnosed Multiple Myeloma with Differential Circulating Clonal Plasma Cells.
- Published in:
- Biomedicines, 2022, v. 10, n. 2, p. 209, doi. 10.3390/biomedicines10020209
- By:
- Publication type:
- Article
Percutaneous Coronary Intervention Complications: Where do we Stand?
- Published in:
- Rhythmos, 2015, v. 10, n. 1, p. 5
- By:
- Publication type:
- Article